0000920465-19-000032.txt : 20190213 0000920465-19-000032.hdr.sgml : 20190213 20190213182524 ACCESSION NUMBER: 0000920465-19-000032 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190213 DATE AS OF CHANGE: 20190213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TIDMARSH GEORGE F CENTRAL INDEX KEY: 0001287235 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 19599456 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 5 1 wf-form5_155010030902407.xml FORM 5 X0306 5 2018-12-31 0 0 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001287235 TIDMARSH GEORGE F C/O LA JOLLA PHARMACEUTICAL COMPANY, 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 1 1 0 0 President, CEO & Secretary Common Stock 2018-06-08 5 G 0 17742 0 D 1266704 D Common Stock 2018-06-08 5 G 0 900 0 D 1265804 D Common Stock 2018-06-08 5 G 0 900 0 D 1264904 D Common Stock 2018-06-08 5 G 0 900 0 D 1264004 D Common Stock 2018-06-08 5 G 0 900 0 D 1263104 D Common Stock 22000 I By children /s/ Ryan Murr, as attorney-in-fact for George F. Tidmarsh 2019-02-13